Protagonist Therapeutics: Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in beta-thalassemia, hereditary hemochromatosis, polycythemia vera, and MDS; Phase 2 results and first indication choice for pivotal study expected 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis to begin early 2020; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Gastrointestinal, Hematology, Rare Disease
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Platform Technology
Website:
Address:
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Protagonist Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 15.58 4,094,144 76.31 13F 2020-03-31
RTW Investments LP 10.12 2,660,392 49.59 13F 2020-03-31
Johnson & Johnson Innovation JJDC, Inc. 9.32 2,449,183 45.65 13F 2020-03-31
Adage Capital Management LP 8.37 2,200,000 41.01 Stakes 2020-05-13
Baker Bros. Advisors LP 6.39 1,679,164 31.30 13F 2020-03-31
Farallon Capital Management LLC 5.71 1,500,000 27.96 13F 2020-03-31
The Vanguard Group, Inc. 4.74 1,244,588 23.20 Funds 2020-05-31
Vanguard Group, Inc. (Subfiler) 3.64 957,240 17.84 13F 2020-03-31
BlackRock Fund Advisors 3.40 894,718 16.68 13F 2020-03-31
JPMorgan Investment Management, Inc. 2.94 772,125 14.39 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.